165 Juvenile Idiopathic Arthritis (JIA); How Do Clinicians Define Remission and Withdraw Etanercept?

Pediatric Research - United States
doi 10.1203/00006450-201011001-00165
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

How Do Parents of Children With Juvenile Idiopathic Arthritis (JIA) Perceive Their Therapies?

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2008English

14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): Can Extension Be Predicted?

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2008English

Discontinuation of Etanercept After Successful Treatment in Patients With Juvenile Idiopathic Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2010English

Long-Term Outcomes in Juvenile Idiopathic Arthritis: 18 Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis (JIA) Cohort

Arthritis Care and Research
Rheumatology
2020English

Time of Onset of Iridocyclitis (IC) in Children With Juvenile Idiopathic Arthritis (JIA)

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2008English

Juvenile Idiopathic Arthritis

The Lancet
Medicine
2007English

Juvenile Idiopathic Arthritis

2018English

Juvenile Idiopathic Arthritis

Nederlands Tijdschrift voor Tandheelkunde
Medicine
2018English

Juvenile Idiopathic Arthritis

2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy